2005
Technetium Tc 99m–Labeled Red Blood Cells in the Preoperative Diagnosis of Cavernous Hemangioma and Other Vascular Orbital Tumors
Abstract: To evaluate technetium Tc 99m (99m Tc) red blood cell scintigraphy as a diagnostic tool for orbital cavernous hemangioma and to differentiate between orbital masses on the basis of their vascularization. Methods: We performed 99m Tc red blood cell scintigraphy on 23 patients (8 female and 15 male; mean age, 47 years) affected by an orbital mass previously revealed with computed tomography (CT) and magnetic resonance imaging (MRI) and suggesting cavernous hemangioma. In our diagnosis, we considered the orbital …
Search citation statements
Paper Sections
Select...
19
2
1
0
Citation Types
3
10
0
1
Year Published
Range
2006
2026
Publication Types
Select...
19
2
Relationship
0
21
Authors
Journals
Cited by 21 publications
(14 citation statements)
References 11 publications
3
10
0
1
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Burroni et al (30) reported that the characteristics of CHMs on SPECT imaging include the absence of intake during the early blood pool phase, followed by focal intake with persistent high consistency in the late phase. Additionally, false positive results were found within one hemangiopericytoma and one lymphangioma (both vascular diseases), which is consistent with the findings by Polite et al (31); thus, more accurate CHM diagnosis is needed via combination with clinical manifestations, as well as CT and MRI manifestations. Nevertheless, the high sensitivity and specificity of SPECT imaging cannot be ignored.…”
Section: Mtc-rbc Spect
supporting
confidence: 88%